The largest database of trusted experimental protocols

Bordetella pertussis toxin

Manufactured by Chondrex

Bordetella pertussis toxin is a protein produced by the bacterium Bordetella pertussis, the causative agent of whooping cough. This toxin is commonly used in research applications to study the immune response and pathogenic mechanisms associated with Bordetella pertussis infections.

Automatically generated - may contain errors

2 protocols using bordetella pertussis toxin

1

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourteen-week-old mice were immunized subcutaneously with 150 μg of myelin oligodendrocyte glycoprotein peptide (residues 35–55; MOG35–55; Bio-Synthesis, TX) emulsified in complete Freund’s adjuvant (CFA; Chondrex, Redmond, WA) containing 2.5 mg/ml heat-killed Mycobacterium tuberculosis. Mice were injected intraperitoneally with 250 ng Bordetella pertussis toxin (Chondrex) the day of, and again, 2 days following MOG35–55 immunization. At 21–28 days post-immunization, mice were euthanized for histological analyses. The mice were euthanized by CO2 asphyxiation for 10 min from a compressed gas tank followed by decapitation or cardiac perfusion. Following perfusion, mice were immediately decapitated. EAE clinical manifestations of progressive ascending paralysis were assessed daily using a standard scoring system: 0 = no overt symptoms, 1= loss of tail tone, 2 = hind limb paresis, 3 = complete hind limb paralysis, 4 = hind limb paralysis and forelimb paresis, and 5 = moribund or dead. The mice were weighed daily to ensure weight loss did not exceed 25% of starting weight.
+ Open protocol
+ Expand
2

Induction of Experimental Autoimmune Encephalomyelitis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight- to nine-week-old mice were immunized subcutaneously with 150 μg myelin oligodendrocyte glycoprotein (MOG35–55; Bio-Synthesis, City, TX) emulsified in complete Freund’s adjuvant (CFA; Difco Laboratories, Detroit, MI) containing 2.5 mg/ml heat-killed Myobacterium tuberculosis. Mice were injected intraperitoneally with 250 ng Bordetella pertussis toxin (Chondrex, Redmond, WA) the day of, and 2 days following, MOG35–55 immunization. At 21 days post-immunization, the mice were euthanized for the histological analyses. EAE clinical manifestations of progressive ascending paralysis were assessed daily using a standard scoring system: 1 = loss of tail tone, 2 = hind limb paresis, 3 = complete hind limb paralysis, 4 = hind limb paralysis and forelimb paresis, and 5 = moribund or dead. Mice were weighed daily to ensure weight loss did not exceed 25% of starting weight. All EAE data were gathered in two independent experiments from cohorts of the same 12 WT mice and ten KO mice.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!